In a recent study that investigated how these revolutionary drugs affect the HPG (hypothalamic-pituitary-gonadal) axis found that men without diabetes had a higher chance of developing ED by a very low 1.5%
Molly Maloof, a Stanford lecturer and media personality who reportedly treats many tech execs using peptides today, was quoted as saying that were going to see a lot of the gray market become the white market in the next decade. There are also several international pharmaceutical companies pouring money into alternative delivery systems, like transdermal patches, to appeal to needle-adverse users these could hit the market in the next 18 months
These should be avoided in patients with suspected obstruction, significant dysphagia, or severe gastroparesis symptoms
Kantar M, Sezak M, Turhan T, Kitis O, Mutluer S, et al
The study included 1 511 637 eligible patients with type 2 diabetes without prior diagnosis of any eye disorder who were prescribed antidiabetic medications, including 82 972 patients prescribed semaglutide or tirzepatide (63 926 patients [77.05%] prescribed semaglutide, 3815 patients [4.60%] prescribed tirzepatide, and 15 231 patients [18.36%] prescribed both medications) and 1 428 665 patients prescribed other antidiabetic medications
Cells (2022) 11(9):1513